REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Szabadilla Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: SZABADILLA Gyogyszertari Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Szabadilla Bt. is an enterprise in Hungary, with the main office in Bekescsaba. The company operates in the Pharmacies and Drug Stores industry. Szabadilla Bt. was incorporated on June 20, 1996. 11 (2024) employees currently work for Szabadilla Bt.. From the latest financial highlights, Szabadilla Bt. reported a net sales revenue increase of 12.08% in 2023. During that time, Szabadilla Bt.’s total assets grew by 11.43%. In 2023, Szabadilla Bt.’s net profit margin decreased by 1.19%.

Headquarters
Petofi u.2.
Bekescsaba; Bekes; Postal Code: 5600

Contact Details: Purchase the Szabadilla Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Szabadilla Bt. report to view the information.
Outstanding Shares:
Purchase the Szabadilla Bt. report to view the information.
Registered Capital:
Purchase the Szabadilla Bt. report to view the information.
Incorporation Date:
June 20, 1996
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Csanad Pharma Kft.
Company Performance
Financial values in the chart are available after Szabadilla Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
12.08%▲
Total operating revenue
11.78%▲
Operating profit (EBIT)
-55.05%▼
EBITDA
-50.59%▼
Net Profit (Loss) for the Period
-59.92%▼
Total assets
11.43%▲
Total equity
10.68%▲
Operating Profit Margin (ROS)
-1.26%▼
Net Profit Margin
-1.19%▼
Return on Equity (ROE)
-17%▼
Quick Ratio
-0.17%▼
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo